60 Biggest Movers From Yesterday

Gainers

• Trillium Therapeutics Inc. TRIL shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
• Vivos Therapeutics, Inc. VVOS rose 53.7% to settle at $5.90. The FDA granted 510(k) clearance to Vivos Therapeutics’ mmRNA (modified mandibular Repositioning Nighttime Appliance) obstructive sleep apnea (OSA) device.
• Greenpro Capital Corp. GRNQ gained 34.2% to close at $1.02. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X signed a Memorandum of Understanding with Silkwave Holdings to form a joint venture partnership to develop a GEO-LEO integrated satellite Network and services platform.
• Canoo Inc. GOEV jumped 31.8% to close at $7.79.
• Pixelworks, Inc. PXLW jumped 29.2% to close at $5.75 following a 25% surge on Friday.
• Equillium, Inc. EQ gained 26.9% to close at $6.14. Equillium recently announced additional data from the Type A portion of the EQUALISE Phase 1b study of itolizumab in systemic lupus erythematosus (SLE) and lupus nephritis (LN).
• Support.com, Inc. SPRT rose 26.8% to settle at $11.17.
• KLX Energy Services Holdings, Inc. KLXE gained 26% to close at $5.77 amid a weaker US dollar.
• Candel Therapeutics, Inc. CADL jumped 25.9% to close at $7.93. UBS and Jefferies initiated coverage on the stock with a Buy rating.
• Endo International plc ENDP rose 25.8% to close at $2.68 after dropping 40% on Friday. Endo International, earlier during the month, posted upbeat quarterly results.
• City Office REIT, Inc. CIO shares surged 24.8% to settle at $16.10 after the company agreed to sell all of its holdings in the Sorrento Mesa submarket of San Diego for $576 million.
• ABVC BioPharma, Inc. ABVC gained 23.7% to close at $2.51. ABVC BioPharma recently reported Q2 earnings results.
• CASI Pharmaceuticals, Inc. CASI surged 23.3% to close at $1.59. CASI Pharmaceuticals Chairman & CEO Wei-Wu He acquired a total of 480000 shares at an average price of $1.28.
• Xeris Pharmaceuticals, Inc. XERS gained 21.4% to close at $2.67 after the company announced FDA approval of its New Drug Application for Gvoke for the treatment of severe hypoglycemia.
• Biomea Fusion, Inc. BMEA gained 17.7% to settle at $13.15. Biomea Fusion CEO Butler reported the purchase of 204,470 shares at an average price of $16.15 per share in Form 4 filing on Thursday.
• Vincerx Pharma, Inc. VINC surged 17.5% to close at $13.94. Vincerx Pharma recently posted a Q2 loss of $0.12 per share.
• Romeo Power, Inc. RMO jumped 17.5% to close at $5.04.
• CleanSpark, Inc. CLSK gained 17% to settle at $12.62.
• Flexion Therapeutics, Inc. FLXN jumped 16.7% to close at $5.46.
• Rekor Systems, Inc. REKR gained 16.4% to settle at $7.81. The company, last week, reported downbeat quarterly results.
• Icosavax, Inc. ICVX gained 16.3% to settle at $40.25 after multiple firms initiated coverage on the stock with bullish ratings and price targets, respectively.
• Meta Materials Inc. MMAT surged 16.3% to close at $3.35.
• Eos Energy Enterprises, Inc. EOSE rose 16.3% to settle at $13.41. EOS Energy Enterprises recently reported worse-than-expected Q2 EPS and sales results.
• HyreCar Inc. HYRE climbed 16.2% to close at $10.17.
• Madison Square Garden Entertainment Corp. MSGE gained 16.2% to close at $72.55 after the company reported better-than-expected Q4 sales results.
• Catabasis Pharmaceuticals, Inc. CATB jumped 16.1% to settle at $8.80.
• ALX Oncology Holdings Inc. ALXO gained 16.1% to settle at $72.64 in sympathy with Trillium Therapeutics which announced an acquisition by Pfizer Monday.
• Huaneng Power International, Inc. HNP gained 16% to close at $19.16.
• Singular Genomics Systems, Inc. OMIC jumped 16% to settle at $16.59.
• Bicycle Therapeutics plc BCYC gained 16% to close at $33.20. Bicycle Therapeutics, earlier during the month, posted a Q2 loss of $0.74 per share.
• Nuvation Bio Inc. NUVB rose 15.9% to settle at $9.32.
• Velodyne Lidar, Inc. VLDR gained 15.8% to close at $7.15 after company founder David Hall called for Chairman Michael Dee and Director Hamid Zarringhalam to resign from the board.
• NRx Pharmaceuticals, Inc. NRXP rose 15.7% to settle at $13.78.
• Bristow Group Inc. VTOL climbed 15.3% to close at $30.32.
• Dynavax Technologies Corporation DVAX gained 14.4% to close at $13.77. Medigen Vaccine Biologics Corporation and Dynavax Technologies announced the rollout of their COVID-19 vaccine, MVC-COV1901, in Taiwan.
• Doximity, Inc. DOCS rose 14.4% to close at $87.15.
• NeuroOne Medical Technologies Corporation NMTC gained 14.2% to close at $4.42 after the company reported a strategic partnership with RBC Medical Innovations for Ablation Program.
• Landmark Infrastructure Partners LP LMRK gained 14.1% to close at $16.16 as the company agreed to be acquired by its sponsor, Landmark Dividend LLC for $16.50 per unit.
• Couchbase, Inc. BASE gained 14% to close at $42.95.
• Canaan Inc. CAN rose 13.8% to close at $9.17 in sympathy with the price of Bitcoin.
• BeyondSpring Inc. BYSI shares gained 13.7% to close at $22.96.
• Butterfly Network, Inc. BFLY rose 12.7% to settle at $11.46.
• BioNTech SE BNTX jumped 9.6% to settle at $382.10. The FDA has approved Pfizer and BioNTech’s COVID-19 vaccine, making it the first to receive full FDA approval.
• Editas Medicine, Inc. EDIT gained 8.3% to close at $65.36 after the company announced it presented data on new SLEEK gene editing technology at the Cold Spring Harbor Laboratory's Genome Engineering: CRISPR Frontiers meeting.
• Shattuck Labs, Inc. STTK gained 6.5% to close at $21.24.
• Yunhong CTI Ltd. CTIB gained 5.5% to settle at $1.91. Yunhong CTI recently reported a deal to sell its Flexo Universal Unit for $500,000.
• PharmaCyte Biotech, Inc. PMCB gained 5.2% to close at $3.66. PharmaCyte Biotech recently announced a $70 million registered direct offering priced at-the-market under Nasdaq rules.

Check out these big penny stock gainers and losers

Losers

• Regencell Bioscience Holdings Limited RGC dripped 28.3% to close at $13.74 on Monday after jumping over 200% on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.
• MarketWise, Inc. MKTW fell 16.7% to settle at $6.79. Marketwise recently reported Q2 sales of $142.10 million.
• Staffing 360 Solutions, Inc. STAF shares fell 13% to close at $1.77 after the company announced a 1.36 million share stock offering priced at $2.10 per share.
• Flora Growth Corp. FLGC fell 12.2% to settle at $11.14. Flora Growth shares surged 44% on Friday after the company reported its financial and operating results for the six months ending June 30, 2021, revealing revenues of over $2 million, compared to revenues of approximately $100 000 in the same period of last year.
• Mercurity Fintech Holding Inc. MFH dropped 11.7% to settle at $3.01.
• Airspan Networks Holdings Inc. MIMO fell 10.2% to close at $6.80. Airspan Networks, on Friday, reported Q2 sales of $42.00 million, up from $27.80 million year over year.
• Evolv Technologies Holdings, Inc. EVLV dropped 10.2% to close at $8.08. The company, last week, reported a wider quarterly loss.
• XTL Biopharmaceuticals Ltd. XTLB dipped 9.6% to settle at $4.15.
• Moxian, Inc. MOXC fell 9.4% to settle at $6.36.
• Century Therapeutics, Inc. IPSC dropped 8.5% to close at $24.06. Century Therapeutics recently posted a Q2 loss of $1.93 a share.
• Zhihu Inc. ZH fell 8.1% to close at $9.42 after gaining 15% on Friday. The company recently said its revenue rose 144% year-on-year.
• Eastside Distilling, Inc. EAST fell 7.4% to settle at $2.89. Eastside Distilling recently posted a Q2 loss of $0.14 a share.
• Yiren Digital Ltd. YRD dropped 5.7% to close at $3.50. The company recently said it swung to a Q2 profit.